STAT+: Pharmalittle: We’re reading about Lilly strategy against compounders, Bristol’s antipsychotic, and more
STAT
APRIL 23, 2025
The gambit was prompted by the penalties that companies must pay to Medicaid when they raise the price of a medicine above the inflation rate, a consequence of a provision in a federal law that went into effect in early 2024. saying it will encourage innovation , The Financial Times notes. ” The U.S. government estimates.
85 
Let's personalize your content